Wendell David Associates’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-8,000
| Closed | -$794K | – | 155 |
|
|
2019
Q3 | $794K | Sell |
8,000
-1,390
| -15% | -$132K | 0.12% | 97 |
|
|
2019
Q2 | $868K | Sell |
9,390
-4,985
| -35% | -$473K | 0.13% | 94 |
|
|
2019
Q1 | $1.36M | Sell |
14,375
-63,985
| -82% | -$5.6M | 0.21% | 85 |
|
|
2018
Q4 | $5.02M | Sell |
78,360
-2,420
| -3% | -$179K | 0.9% | 36 |
|
|
2018
Q3 | $7.23M | Sell |
80,780
-660
| -0.8% | -$58.3K | 1.13% | 28 |
|
|
2018
Q2 | $6.47M | Sell |
81,440
-4,650
| -5% | -$386K | 1.1% | 28 |
|
|
2018
Q1 | $7.68M | Sell |
86,090
-6,935
| -7% | -$666K | 1.38% | 23 |
|
|
2017
Q4 | $9.71M | Buy |
93,025
+290
| +0.3% | +$32.7K | 1.66% | 20 |
|
|
2017
Q3 | $13.5M | Buy |
92,735
+3,735
| +4% | +$509K | 2.39% | 10 |
|
|
2017
Q2 | $11.6M | Sell |
89,000
-1,215
| -1% | -$149K | 2.18% | 15 |
|
|
2017
Q1 | $11.2M | Sell |
90,215
-1,770
| -2% | -$212K | 2.15% | 14 |
|
|
2016
Q4 | $10.6M | Buy |
91,985
+270
| +0.3% | +$30.1K | 2.1% | 14 |
|
|
2016
Q3 | $9.59M | Buy |
91,715
+125
| +0.1% | +$13.5K | 1.89% | 17 |
|
|
2016
Q2 | $9.07M | Sell |
91,590
-1,315
| -1% | -$136K | 1.78% | 16 |
|
|
2016
Q1 | $9.29M | Buy |
92,905
+590
| +0.6% | +$60.8K | 1.8% | 18 |
|
|
2015
Q4 | $11.1M | Buy |
92,315
+1,720
| +2% | +$199K | 2.19% | 14 |
|
|
2015
Q3 | $9.78M | Sell |
90,595
-1,070
| -1% | -$133K | 2.01% | 15 |
|
|
2015
Q2 | $10.6M | Sell |
91,665
-1,475
| -2% | -$169K | 2.06% | 16 |
|
|
2015
Q1 | $10.7M | Buy |
93,140
+990
| +1% | +$118K | 2.06% | 15 |
|
|
2014
Q4 | $10.3M | Buy |
92,150
+1,610
| +2% | +$170K | 2.01% | 15 |
|
|
2014
Q3 | $8.6M | Buy |
90,540
+2,480
| +3% | +$224K | 1.79% | 21 |
|
|
2014
Q2 | $7.57M | Buy |
88,060
+8,290
| +10% | +$630K | 1.59% | 22 |
|
|
2014
Q1 | $5.58M | Buy |
79,770
+4,430
| +6% | +$351K | 1.21% | 28 |
|
|
2013
Q4 | $6.37M | Buy |
75,340
+700
| +0.9% | +$55.4K | 1.4% | 25 |
|
|
2013
Q3 | $5.75M | Buy |
74,640
+580
| +0.8% | +$40.6K | 1.38% | 25 |
|
|
2013
Q2 | $4.33M | Buy |
+74,060
| New | +$4.46M | 1.08% | 28 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Wendell David Associates's CELG Position: Q4 2019 in Review
Wendell David Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,000 shares — an estimated $794K sold.
Wendell David Associates first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $13.5M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Wendell David Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Wendell David Associates sold 8,000 Celgene Corp shares in Q4 2019, an estimated $794K.
- Wendell David Associates first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Wendell David Associates's Celgene Corp position peaked at $13.5M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Wendell David Associates's 13F filing for Q4 2019, filed 17 Jan 2020.